These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10918474)

  • 1. Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors.
    Martino G; Poliani PL; Marconi PC; Comi G; Furlan R
    Gene Ther; 2000 Jul; 7(13):1087-93. PubMed ID: 10918474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
    Furlan R; Poliani PL; Marconi PC; Bergami A; Ruffini F; Adorini L; Glorioso JC; Comi G; Martino G
    Gene Ther; 2001 Jan; 8(1):13-9. PubMed ID: 11402297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach.
    Martino G; Poliani PL; Furlan R; Marconi P; Glorioso JC; Adorini L; Comi G
    J Neuroimmunol; 2000 Jul; 107(2):184-90. PubMed ID: 10854655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination.
    Furlan R; Poliani PL; Galbiati F; Bergami A; Grimaldi LM; Comi G; Adorini L; Martino G
    Hum Gene Ther; 1998 Nov; 9(17):2605-17. PubMed ID: 9853527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis.
    Poliani PL; Brok H; Furlan R; Ruffini F; Bergami A; Desina G; Marconi PC; Rovaris M; Uccelli A; Glorioso JC; Penna G; Adorini L; Comi G; 't Hart B; Martino G
    Hum Gene Ther; 2001 May; 12(8):905-20. PubMed ID: 11387056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Ruffini F; Furlan R; Poliani PL; Brambilla E; Marconi PC; Bergami A; Desina G; Glorioso JC; Comi G; Martino G
    Gene Ther; 2001 Aug; 8(16):1207-13. PubMed ID: 11509953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity.
    Nygårdas M; Paavilainen H; Müther N; Nagel CH; Röyttä M; Sodeik B; Hukkanen V
    PLoS One; 2013; 8(5):e64200. PubMed ID: 23700462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
    Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy in autoimmune, demyelinating disease of the central nervous system.
    Baker D; Hankey DJ
    Gene Ther; 2003 May; 10(10):844-53. PubMed ID: 12732870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gene therapy approach to treat demyelinating diseases using non-replicative herpetic vectors engineered to produce cytokines.
    Martino G; Furlan R; Galbiati F; Poliani PL; Bergami A; Grimaldi LM; Adorini L; Comi G
    Mult Scler; 1998 Jun; 4(3):222-7. PubMed ID: 9762678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system.
    Furlan R; Pluchino S; Martino G
    Curr Opin Neurol; 2003 Jun; 16(3):385-92. PubMed ID: 12858077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis.
    Broberg E; Setälä N; Röyttä M; Salmi A; Erälinna JP; He B; Roizman B; Hukkanen V
    Gene Ther; 2001 May; 8(10):769-77. PubMed ID: 11420640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis.
    Butti E; Bergami A; Recchia A; Brambilla E; Del Carro U; Amadio S; Cattalini A; Esposito M; Stornaiuolo A; Comi G; Pluchino S; Mavilio F; Martino G; Furlan R
    Gene Ther; 2008 Apr; 15(7):504-15. PubMed ID: 18239607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitis.
    Broberg EK; Salmi AA; Hukkanen V
    Neurosci Lett; 2004 Jul; 364(3):173-8. PubMed ID: 15196670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy-mediated modulation of immune processes in the central nervous system.
    Furlan R; Pluchino S; Martino G
    Curr Pharm Des; 2003; 9(24):2002-8. PubMed ID: 12871186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle.
    Makar TK; Bever CT; Singh IS; Royal W; Sahu SN; Sura TP; Sultana S; Sura KT; Patel N; Dhib-Jalbut S; Trisler D
    J Neuroimmunol; 2009 May; 210(1-2):40-51. PubMed ID: 19361871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
    Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis.
    Slaets H; Hendriks JJ; Van den Haute C; Coun F; Baekelandt V; Stinissen P; Hellings N
    Mol Ther; 2010 Apr; 18(4):684-91. PubMed ID: 20068552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of microRNA-155 in the mechanism of electroacupuncture treatment effects on experimental autoimmune encephalomyelitis.
    Zhao P; Chen X; Han X; Wang Y; Shi Y; Ji J; Lei Y; Liu Y; Kong Q; Mu L; Wang J; Zhao W; Wang G; Liu X; Zhang T; Zhang Y; Sun B; Liu Y; Li H
    Int Immunopharmacol; 2021 Aug; 97():107811. PubMed ID: 34091117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.